|EKGGF -- USA Stock|| |
USD 0.04 0.00 0.00%
Dr. Anatoly Langer M.D. is Chairman of the Board of the Company. He is graduated from the University of Manitoba in 1982 and completed his Internal Medicine and Cardiology training at the University of Toronto in 1987. He is a fellow of the American College of Cardiology and Canadian Royal College of Physicians and Surgeons. After two years as a Heart and Stroke Foundation Research Fellow he became a director of the Coronary Care Unit at St. Michael Hospital in Toronto Canada . In 1996 Dr. Langer founded the Canadian Heart Research Centre with the goal of improving the care of cardiovascular patients through clinical trials research and education. Dr. Langer has over 200 peer reviewed publications abstracts and book chapters. His areas of interest and research include pathophysiology and the management of acute and stable coronary syndromes as well as the treatment and prevention of cardiovascular disease. Currently Dr. Langer is a Professor of Medicine at the University of Toronto and a staff cardiologist at St Michael Hospital. He is Chair of the Canadian Heart Research Centre in Toronto . Dr. Langer has research experience in the conduct of clinical trials with over 15 years of experience in protocol design study coordination and data management.
Chairman Since 2010
The company has return on total asset (ROA)
of (7.45) %
which means that it has lost $7.45 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (69.43) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 451.03 K in total debt with debt to equity ratio (D/E) of 259.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CardioComm Solutions has Current Ratio of 1.2 suggesting that it is not liquid enough and may have problems to pay out its financial obligations in time and when they become due.
CardioComm Solutions, Inc., together with its subsidiary, CardioView Inc., develops software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. CardioComm Solutions operates under Health Information Services classification in USA and traded on OTC Market.CardioComm Solutions (EKGGF) is traded on OTC Market in USA. It is located in 259 Yorkland Road and employs 10 people.
CardioComm Solutions Leadership Team
|Etienne Grima, CEO, Corporate Secretary, Director and Member of Audit Committee|
|William Smith, Independent Director|
|Steven Benyo, Director|
|Robert Caines, Director|
|Yury Levin, Independent Director|
|David Newman, Independent Director|
|Simi Grosman, Director|
|John Foote, Director|
|Anatoly Langer, Chairman of the Board|
|John Overall, CFO|
|Margaret Helms, Director|
|Wendy Hsieh, CFO|
Stock Performance Indicators